The RECUPERA project, led by DyCare and Ephion Health in collaboration with Vall d’Hebron, Eurecat, and the Ictus Foundation, will combine AI, computer vision, and biomechanical sensors to measure patient progress and tailor exercises to their needs.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The CHANCE study analyzes the outcomes of nearly 1,000 patients at 63 liver transplant centers and identifies which patients with the most severe forms of the disease may benefit from transplantation.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The exhibition, produced by the Vall d’Hebron Radiology Department through the FUSMED research line of the Molecular Imaging and Therapy Group at the Vall d’Hebron Institut de Recerca (VHIR), brings knowledge about ultrasound and its applications in medicine closer to the public.

Més de 150 persones participen en els tallers de Vall d'Hebron a la Nit de la Recerca

From 22 to 23 October, the 3rd International Congress on Health Communication, organised by Vall d’Hebron with the support of the European University Hospital Alliance (EUHA), will feature live connections with health activities taking place around the world.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

Professionals from Vall d’Hebron have taken part in outreach activities on clinical trials and epidemiology, as well as in a round table on the future of the relationship between microorganisms and society.

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

The charitable initiative, launched by the Terrassa Municipal Police, funds the doctoral thesis of predoctoral researcher María Gallego.

The technology could help make stool sample screening more comprehensive and facilitate the identification of parasitic findings for subsequent expert review.

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The meeting, the most important event in the field worldwide, took place in Barcelona from 5 to 9 September and featured presentations of more than thirty VHIR studies.

The researcher from the VHIR Pulmonology group aims to continue promoting prevention, research and respiratory health advocacy, while strengthening the international profile of research teams in Spain and Catalonia.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

The team has discovered that a protein called SEC22B acts as a phenotype modifier and could be used as a potential urinary marker of the disease.

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

16 VHIR professionals have participated in specialized training in innovation and entrepreneurship in health, culminating in a project competition and the awarding of the first prize for the best pitch.

The study shows that cell-free mitochondrial DNA does not directly reflect the injury caused by warm ischemia in the donor lung, but rather that its post-transplant levels are associated with the recipient’s inflammatory response.

The DETECTIVE doctoral network, coordinated by the University of Turku and funded by the Marie Skłodowska-Curie Actions of the Horizon Europe programme, will train 14 predoctoral researchers in five countries.